Cited by 94Bariatric Surgery and OutcomesBody Contouring and SurgeryMinimally Invasive Surgical Techniques

Cardiovascular benefits of bariatric surgery in morbidly obese patients

Open access
Athyros, V. G., Tziomalos, K., Karagiannis, A., Mikhailidis, D. P.·2011·Obesity Reviews

Abstract

Morbid obesity is associated with increased morbidity and represents a major healthcare problem with increasing incidence worldwide. Bariatric surgery is considered an effective option for the management of morbid obesity. We searched MEDLINE, Current Contents and the Cochrane Library for papers published on bariatric surgery in English from 1 January 1990 to 20 July 2010. We also manually checked the references of retrieved articles for any pertinent material. Bariatric surgery results in resolution of major comorbidities including type 2 diabetes mellitus, hypertension, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease, nephropathy, left ventricular hypertrophy and obstructive sleep apnea in the majority of morbidly obese patients. Through these effects and possibly other independent mechanisms bariatric surgery appears to reduce cardiovascular morbidity and mortality. Laparoscopic Roux-en-Y gastric bypass (LRYGB) appears to be more effective than laparoscopic adjustable gastric banding (LAGB) in terms of weight loss and resolution of comorbidities. Operation-associated mortality rates after bariatric surgery are low and LAGB is safer than LRYGB. In morbidly obese patients bariatric surgery is safe and appears to reduce cardiovascular morbidity and mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1467-789x.2010.00831.x

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Amelioration of metabolic syndrome, chronic kidney disease, left ventricular hypertrophy, and nonalcoholic fatty liver disease are seen after bariatric surgery.

    “Also, amelioration of other obesity-related comorbidities including metabolic syndrome, chronic kidney disease, left ventricular hypertrophy, and nonalcoholic fatty liver disease are seen after bariatric surgery [61].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P.
Affiliations
  • Aristotle University of Thessaloniki (GR)
  • The Royal Free Hospital (GB)
Corresponding author
Mikhailidis, D. P.
Venue
Obesity Reviews
Publisher
Wiley
Published
2011-02-23
Volume
12
Issue
7
Pages
515-524
ISSN
  • 1467-7881 (ISSN-L)
  • 1467-789X
OpenAlex
W1481484713
Cited by
94
References
98
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 12
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • Obesity Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Surgery › Body Contouring and Surgery
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
Keywords
bariatric surgery, morbid obesity, cardiovascular morbidity, cardiovascular mortality, laparoscopic Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, comorbidity resolution, type 2 diabetes, hypertension, metabolic syndrome, non-alcoholic fatty liver disease, left ventricular hypertrophy, obstructive sleep apnea, weight loss, postoperative mortality
MeSH terms
Diabetes Mellitus, Type 2, Fatty Liver, Humans, Hypertension, Kidney Diseases, Obesity, Morbid, Laparoscopy, Meta-Analysis as Topic, Gastric Bypass, Weight Loss, Comorbidity, Body Mass Index, Treatment Outcome, Hypertrophy, Left Ventricular, Sleep Apnea, Obstructive, Metabolic Syndrome, Bariatric Surgery, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review